Fetalix strengthens innovation pathway through licensing agreement
Technology licensing plays a key role in translating academic research into real-world healthcare solutions, enabling scientific discoveries to progress from the laboratory toward clinical and commercial application.
The science behind Fetalix published in Biomaterials Advances
The PhD research of our co-founder, Morena Francesca Fiordalisi, was published in Biomaterials Advances. The study investigates how the age of the donor tissue used to derive extracellular matrix (ECM) biomaterials influences intervertebral disc regeneration.
Fetalix featured on 90 Segundos de Ciência
Communicating scientific research to the wider public is an important part of fostering awareness of emerging healthcare innovations and their potential societal impact. Science communication initiatives help bridge the gap between research and society, making complex scientific topics more accessible to diverse audiences.
